We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
By Kim Richters
Siemens Healthineers AG said Thursday that it has released a test kit to diagnose infection with the new coronavirus and is seeking emergency-use approvals from authorities.
The German medical equipment maker said its molecular Fast Track Diagnostics SARS-CoV-2 Assay test kit can diagnose infection in less than three hours.
It is applying for emergency approvals for clinical use with the U.S. Food and Drug Administration and the World Health Organization, it said.
The company said it was already supplying tests within the European Union for research use, to speed up availability and expand production capacity for the kit.
"The Siemens Healthineers assay is designed to help researchers positively identify the virus in less than three hours so that healthcare professionals can proceed as quickly as possible with the necessary next steps on their patients' triage paths," the company's head of molecular diagnostics Sebastian Kronmueller said.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
April 02, 2020 08:54 ET (12:54 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Siemens Healthineers Chart |
1 Month Siemens Healthineers Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions